Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PGAP1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | FBXL18 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | LINC00675 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | PRSS56 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | TRAF3IP2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | LRRTM4 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | CDK19 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | GOLGA6L10 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | ETV3 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | HDLBP | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |